Rizici transfuzije i dileme

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (otvara novi prozor)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Izvor‎: Surgery 2012;152(3):344-54.

Indeks‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (otvara novi prozor)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (otvara novi prozor)

Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB.

Izvor‎: Arch Surg 2012;147(1):49-55.

Indeks‎: PubMed 22250113

DOI‎: 10.1001/archsurg.2011.790

https://www.ncbi.nlm.nih.gov/pubmed/22250113 (otvara novi prozor)

Adverse blood transfusion outcomes: establishing causation. (otvara novi prozor)

Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A.

Izvor‎: Transfus Med Rev 2011;25(2):89-101.

Indeks‎: PubMed 21345639

DOI‎: 10.1016/j.tmrv.2010.11.001

https://www.ncbi.nlm.nih.gov/pubmed/21345639 (otvara novi prozor)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (otvara novi prozor)

Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH.

Izvor‎: Crit Care Med 2006;34(6):1608-16.

Indeks‎: PubMed 16607235

DOI‎: 10.1097/01.CCM.0000217920.48559.D8

https://www.ncbi.nlm.nih.gov/pubmed/16607235 (otvara novi prozor)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (otvara novi prozor)

Marik PE, Corwin HL.

Izvor‎: Crit Care Med 2008;36(9):2667-74.

Indeks‎: PubMed 18679112

DOI‎: 10.1097/CCM.0b013e3181844677

https://www.ncbi.nlm.nih.gov/pubmed/18679112 (otvara novi prozor)

Survival rate changes with transfusion of blood products during liver transplantation. (otvara novi prozor)

Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A.

Izvor‎: Can J Anaesth 2005;52(2):148-55.

Indeks‎: PubMed 15684254

DOI‎: 10.1007/BF03027720

https://www.ncbi.nlm.nih.gov/pubmed/15684254 (otvara novi prozor)

Emerging infectious disease agents and their potential threat to transfusion safety. (otvara novi prozor)

Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY.

Izvor‎: Transfusion 2009;49 Suppl 2:1S-29S.

Indeks‎: PubMed 19686562

DOI‎: 10.1111/j.1537-2995.2009.02279.x

https://www.ncbi.nlm.nih.gov/pubmed/19686562 (otvara novi prozor)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (otvara novi prozor)

Stramer SL.

Izvor‎: ISBT Sci Ser 2014;9(1):30-6.

Indeks‎: PubMed 25210533

DOI‎: 10.1111/voxs.12070

https://www.ncbi.nlm.nih.gov/pubmed/25210533 (otvara novi prozor)

PERIOPERATIVNA NEGA

Rizici transfuzije i dileme

srpski (latinica)

Rizici transfuzije i dileme

https://assetsnffrgf-a.akamaihd.net/assets/ct/46e9307b0a/images/syn_placeholder_sqr.png

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (otvara novi prozor)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (otvara novi prozor)

Adverse blood transfusion outcomes: establishing causation. (otvara novi prozor)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (otvara novi prozor)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (otvara novi prozor)

Survival rate changes with transfusion of blood products during liver transplantation. (otvara novi prozor)

Emerging infectious disease agents and their potential threat to transfusion safety. (otvara novi prozor)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (otvara novi prozor)

Kontakt s lokalnim predstavnicima

Medicinske informacije

Filmovi

Intervju sa Pijom di Benedeto, dr med.

Rizici transfuzije i dileme

Izaberi jezik

Podeli